A detailed history of State Of Tennessee, Treasury Department transactions in Vericel Corp stock. As of the latest transaction made, State Of Tennessee, Treasury Department holds 22,487 shares of VCEL stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,487
Previous 23,389 3.86%
Holding current value
$1.23 Million
Previous $1.07 Million 11.46%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$42.25 - $53.56 $38,109 - $48,311
-902 Reduced 3.86%
22,487 $950,000
Q2 2024

Aug 13, 2024

SELL
$41.71 - $52.9 $9,176 - $11,638
-220 Reduced 0.93%
23,389 $1.07 Million
Q1 2024

May 14, 2024

SELL
$32.52 - $52.33 $105,592 - $169,915
-3,247 Reduced 12.09%
23,609 $1.23 Million
Q4 2023

Feb 14, 2024

SELL
$30.85 - $37.09 $55,437 - $66,650
-1,797 Reduced 6.27%
26,856 $956,000
Q2 2023

Aug 15, 2023

BUY
$29.0 - $38.37 $21,315 - $28,201
735 Added 2.63%
28,653 $1.08 Million
Q1 2023

May 12, 2023

SELL
$23.85 - $31.34 $117,580 - $154,506
-4,930 Reduced 15.01%
27,918 $818,000
Q4 2022

Feb 15, 2023

BUY
$17.65 - $27.37 $3,247 - $5,036
184 Added 0.56%
32,848 $866,000
Q3 2022

Jan 26, 2023

BUY
$22.62 - $32.54 $43,814 - $63,029
1,937 Added 6.3%
32,664 $758,000
Q2 2022

Aug 15, 2022

SELL
$22.88 - $39.45 $6,063 - $10,454
-265 Reduced 0.86%
30,727 $773,000
Q1 2022

May 11, 2022

BUY
$31.69 - $43.29 $148,309 - $202,597
4,680 Added 17.79%
30,992 $1.19 Million
Q3 2021

Nov 12, 2021

SELL
$46.35 - $59.75 $36,013 - $46,425
-777 Reduced 2.87%
26,312 $1.29 Million
Q2 2021

Aug 11, 2021

BUY
$47.2 - $67.81 $505,512 - $726,245
10,710 Added 65.39%
27,089 $1.42 Million
Q1 2021

May 10, 2021

BUY
$30.93 - $59.48 $506,602 - $974,222
16,379 New
16,379 $910,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.59B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track State Of Tennessee, Treasury Department Portfolio

Follow State Of Tennessee, Treasury Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.